Nearly 80% of adults with a previous SARS-CoV-2 infection demonstrated a loss of smell up to 2 years later, according to a ...
Immune checkpoint inhibitors have revolutionized cancer treatment, but their effectiveness is limited by the immune status of the patient. In many cases, patients with immunologically cold ...
In a study recently published in the renowned journal Allergy, a MedUni Vienna research team shows that COVID-19 leads to considerable long-term changes in the immune system, even in mild cases. The ...
The ongoing unprecedented outbreak of pneumonia caused by a novel coronavirus (SARS-CoV-2) in Wuhan, China has highlighted the necessity for readily available, accurate and rapid diagnostic testing ...
A recent review by researchers at Philadelphia College of Osteopathic Medicine (PCOM) shows Chlamydia pneumoniae (Cpn) and SARS-CoV-2 infections may play a role in the pathogenesis of Alzheimer's ...
Authors propose enhancing awareness of risks, close genomic surveillance and early diagnostic tests for symptomatic contacts as part of clinical management of these patients. *Please mention the ...
New study reveals how lingering spike protein in the brain's borders could explain long-term COVID-19 neurological symptoms and highlight vaccines' protective role. Study: Persistence of spike protein ...
An international team of researchers led by scientists at Iowa State University, Weill Cornell Medicine and Children's Hospital of Philadelphia (CHOP) has found that an orphan gene in the SARS-CoV-2 ...
Two of the closest known relatives to SARS-CoV-2 -- a pair of bat coronaviruses discovered by researchers in Laos -- may transmit poorly in people despite being genetically similar to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback